The dosage market size value per capita for Penicillins and Streptomycins in Belarus showed fluctuations over the last decade, with a notable peak in 2021 at $5.14. In 2023, the value stood at $4.79, indicating a slight recovery from a decline in 2022. The CAGR over the past five years indicates moderate growth, driven by an increase in demand around the peak in 2020-2021 due to heightened health awareness.

Future trends to watch:

Anticipated innovations in antibiotic formulations.
Potential changes in healthcare policies impacting drug pricing and distribution.
Increased competition and the influence of generic drug entries on market dynamics.